Delivery of trastuzumab medicinal product for CZMP Institute
Original notice title
Poland – Pharmaceutical products – SZP.281.41.2026 Dostawa produktu leczniczego zawierającego substancję czynną – trastuzumab dla Instytutu „CZMP”
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Award Criteria
Lot 1
Buyer
Name
Instytut „Centrum Zdrowia Matki Polki”
Location
Łódź, POL
Website
Identifier
7292242712
Lots (1)
LOT-0001
Trastuzumab
Trastuzumab (asortyment i ilości szczegółowo opisano w Formularzu Cenowym stanowiącym Załącznik nr 2 do SWZ)
Location
Duration
Category
Selection criteria
Award details
Procurement Details
- Publication date
- 18 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Polish
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 424391-2026
Documents (1)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications